<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="cfr.xsl"?>
<CFRGRANULE xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="CFRMergedXML.xsd">
  <FDSYS>
    <CFRTITLE>21</CFRTITLE>
    <CFRTITLETEXT>Food and Drugs</CFRTITLETEXT>
    <VOL>5</VOL>
    <DATE>2011-04-01</DATE>
    <ORIGINALDATE>2011-04-01</ORIGINALDATE>
    <COVERONLY>false</COVERONLY>
    <TITLE>Indications.</TITLE>
    <GRANULENUM>315.4</GRANULENUM>
    <HEADING>Section 315.4</HEADING>
    <ANCESTORS>
      <PARENT HEADING="Title 21" SEQ="3">Food and Drugs</PARENT>
      <PARENT HEADING="CHAPTER I" SEQ="2">FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED)</PARENT>
      <PARENT HEADING="SUBCHAPTER D" SEQ="1">DRUGS FOR HUMAN USE</PARENT>
      <PARENT HEADING="PART 315" SEQ="0">DIAGNOSTIC RADIOPHARMACEUTICALS</PARENT>
    </ANCESTORS>
  </FDSYS>
  <SECTION>
    <SECTNO>§ 315.4</SECTNO>
    <SUBJECT>Indications.</SUBJECT>
    <P>(a) For diagnostic radiopharmaceuticals, the categories of proposed indications for use include, but are not limited to, the following:</P>
    <P>(1) Structure delineation;</P>
    <P>(2) Functional, physiological, or biochemical assessment;</P>
    <P>(3) Disease or pathology detection or assessment; and</P>
    <P>(4) Diagnostic or therapeutic patient management.</P>
    <P>(b) Where a diagnostic radiopharmaceutical is not intended to provide disease-specific information, the proposed indications for use may refer to a biochemical, physiological, anatomical, or pathological process or to more than one disease or condition.</P>
  </SECTION>
</CFRGRANULE>
